Keyword :
Select Report Type :
Select Industry :
Select Sector :
Select Category :
Select Geography :

Search Results

Report Title
Price
China Neurology Devices Market Trends Forecast To 2020   $3,500
  • Language: English | #Pages: 55 | Published: Jun-2015 | Region: Global
Single User price :$3,500 Add To Cart
Enterprise Price :$7,000 Add To Cart
Global Corporate Price :$10,500 Add To Cart

 Short Description

 
The Market Intelligence report provides critical market data for China neurology devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. 
It’s vital “cross category comparison” and “cross sub-category comparison” section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.
It covers important categories such as cerebral spinal fluid management devices, interventional neuro-vascular devices, neuro radiosurgery systems, neurostimulation and pain relief devices
 
 
Market Size
Market size in terms of value ($) and volume (units), for each level of segmentation from 2007 to 2014 and forecast till 2020. 
 
Market Growth
Market growth in terms of value ($) and volume (units), for each level of segmentation from 2007 to 2014 and forecast till 2020. 
 
Competitive Analysis
Market share (%) of companies is covered at sector and category level for 2014.
 
Pricing Analysis
Average selling price ($) for each product type from 2007 – 2014 and forecast till 2020.
 
Cross category comparison and cross sub-category comparison – Forecast and historic market growth and market size comparison for various categories and sub-categories from 2007 to 2014 and 2014 to 2020. 
 
Recent Events and Developments
 
Neurology Devices Market Segmentation
Cerebral Spinal Fluid Management Devices
   CSF Shunt
   ICP Monitoring Devices
Interventional Neuro-Vascular Devices
   Aneurysm Clips
   Embolic Systems
   Navigational Systems
Neuro Radiosurgery Systems
   CyberKnife Radiosurgery
   GammaKnife Radiosurgery
Neurostimulation and Pain Relief Devices
   Spinal Cord Stimulation (SCS)
   Deep Brain Stimulation (DBS)
   Vagus Nerve Stimulation (VNS)
   Sacral Nerve Stimulation(SNS)
Note* 
Market segmentation - Sector>Category>Sub-Category>Segment
China Neurostimulation and Pain Relief Devices Market Outlook and Trends Till 2020   $2,450
  • Language: English | #Pages: 24 | Published: May-2015 | Region: Global
Single User price :$2,450 Add To Cart
Enterprise Price :$4,900 Add To Cart
Global Corporate Price :$7,350 Add To Cart

 This research report provides key market trends, market forecasts and competitive scenario of the neurostimulation (neuromodulation) and pain relief devices  in China through 2020. 

 
The product categories covered in this report include: 
• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
 
Scope
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
• Highlights and compares key product categories for growth trends and revenue forecast.
• Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
• Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 
• Market share of companies.
• Average selling price ($) for each product type (2007 to 2020).
• Recent Events and Developments.
 
Why should you buy?
• Build business strategy by identifying the high growth and attractive market categories. 
• Develop competitive strategy based on competitive landscape. 
• Design capital investment strategies based on forecasted high potential segments. 
• Identify potential business partners, acquisition targets and business buyers. 
• Plan for a new product launch and inventory in advance. 
• Prepare management and strategic presentations using the market data. 
• To review unbiased and independent assessment of the market data. 
India Neurostimulation and Pain Relief Devices Market Outlook and Trends Till 2020   $2,450
  • Language: English | #Pages: 25 | Published: May-2015 | Region: Global
Single User price :$2,450 Add To Cart
Enterprise Price :$4,900 Add To Cart
Global Corporate Price :$7,350 Add To Cart
 
This research report provides key market trends, market forecasts and competitive scenario of the neurostimulation and pain relief devices  in India through 2020. 
 
The product categories covered in this report include: 
• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
 
Scope
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
• Highlights and compares key product categories for growth trends and revenue forecast.
• Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
• Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 
• Market share of companies.
• Average selling price ($) for each product type (2007 to 2020).
• Recent Events and Developments.
 
Why should you buy?
• Build business strategy by identifying the high growth and attractive market categories. 
• Develop competitive strategy based on competitive landscape. 
• Design capital investment strategies based on forecasted high potential segments. 
• Identify potential business partners, acquisition targets and business buyers. 
• Plan for a new product launch and inventory in advance. 
• Prepare management and strategic presentations using the market data. 
• To review unbiased and independent assessment of the market data. 
Single User price :$3,007 Add To Cart
Enterprise Price :$6,014 Add To Cart
Global Corporate Price :$9,021 Add To Cart

Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables

 

-       Over 70% Indonesian men (80 million) are chain smokers.

-                       -      Around 400,000 Indonesians die annually due to smoking-related conditions; of these, 6% are passive smokers.

-                      -  Three-fourths of 6.5 million vehicles in Jakarta do not pass the emission test.

Indonesia is the fourth most populous country in the world with almost 5% of the total deaths triggered by respiratory diseases like Chronic Obstructive Pulmonary Disorder (COPD) and Asthma and Obstructive Sleep Apnea (OSA). The Indonesian respiratory device market is forecast to grow at a CAGR of 9% till 2020. The market comprises diagnostic devices such as spirometers and peak flow meters, monitoring devices such as capnographs and pulse oximeters; therapeutic devices such as oxygen concentrators and nebulisers; Continuous Positive Airway Pressure (CPAP) devices, and disposables such as oxygen masks, nasal cannulae and CPAP masks.

The growth in Indonesia market is backed by a rise in smoking habits, increased air pollution, enhanced life expectancy, improved healthcare infrastructure and government initiatives. Though a considerable population of Indonesia is young, due to the rise in smoking habits accompanied by improved life expectancy, chances of developing COPD and other chronic respiratory diseases will rise considerably, which will increase the need for respiratory management and diagnostic devices like nebulisers, peak flow meters, CPAP and spirometers in the near future.

Jakarta is the largest and most polluted city in Indonesia and has the highest number of asthma cases. The air in Jakarta is highly polluted as most vehicles do not pass the emission test that has resulted in an increase in the number of asthma cases, especially in children and a resultant rise in demand for nebulisers. The demand for disposable devices has also increased due to a surge for disposables over reusable ones. 

Indonesia has a wide network of primary healthcare centres called Puskesmas with at least one Puskesma for every 30,000 people. All these centres need basic respiratory devices such as nebulisers, peak flow meters and pulse oximeters in order to provide better healthcare services to the patients. The government insurance programs like Jamkesmas and Universal Health Insurance Coverage to provide free basic healthcare services to all the citizens will also drive the market.

“The Indonesia market is underpenetrated and therefore offers attractive growth opportunities especially for foreign manufactures as it lacks domestic manufacturing facilities. However, low awareness and affordability may restrain the market growth to some extent,” said Uday Sai Ranjan Avula, analyst at ABMRG.

Key players in Indonesian respiratory devices market are AirSep Corporation, a division of Chart Industries, CareFusion Corp (NYSE : CFN), Covidien plc, DeVilbiss Healthcare LLC, Fisher & Paykel Healthcare Corp Ltd (NZSE : FPH), Invacare Corporation, Omron Healthcare, Inc., a division of Omron Corporation (6645: TSE), Philips Respironics, Inc., a division of Koninklijke Philips N.V. (AMS : PHIA, NYSE : PHG), and ResMed Inc (NYSE: RMD).

Indonesia Respiratory Devices and Respiratory Diagnostics Market through 2020 - Detailed analysis of Hospital and Retail market’, a report recently published by ABMRG, reviews historical trends and forecasts (between 2007 and 2020), annualised sales - market size (value and units), market growth, pricing, competitive landscape and market share.

It offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines, product approvals and launches, recalls and litigations, market dynamics, market drivers and restrains.

Why one should buy this report 

The report can be instrumental in making strategic decisions pertaining to:

  • Make a business development strategy for the respiratory devices in Indonesia.
  • Frame a distribution strategy in Indonesia based on a detailed analysis of hospital and retail channel market.
  • Make capital investments based on the forecast for high potential market.
  • Identify in-licensing and out-licensing opportunities, and recognizing potential business partners and M&A targets within the respiratory devices market.
  • Get access to in-depth information and data relating to the Indonesia respiratory devices market.
  • Prepare management and strategic presentations for investors and shareholders.

Other strategic market reports: 

-          ASEAN and Oceania Respiratory Devices and Diagnostics Market Through 2021

http://www.abmrg.com/ASEAN-and-Oceania-Respiratory-Devices-and-Diagnostics-Market-Through-2021.html

-          North America Respiratory Disposable and Anesthesia Disposable Device Market - Growth Trends and Potential 2006-2019

http://www.abmrg.com/North-America-Respiratory-Disposable-Device-Market-Trends-and-Potential-2006-2019.html

About ABMRG

ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on medical technology and pharmaceuticals. It offers comprehensive research and analytical studies targeting company, country and therapeutic sector, highlighting market dynamics, vital trends, business strategies, clinical pipeline and technology advancements. Its cutting edge reports empower companies to make smarter, effective and faster strategic decisions for business growth.

Contact:

Ankit Jian - sales@abmrg.com ; 19@abmrg.com

+91 – 8238155239; +91 - 261-2216406

Source: ABMRG

 

 

 

 

 

 

 

 

US Neurostimulation and Pain Relief Devices Market Outlook and Trends Till 2020   $2,450
  • Language: English | #Pages: 24 | Published: May-2015 | Region: Global
Single User price :$2,450 Add To Cart
Enterprise Price :$4,900 Add To Cart
Global Corporate Price :$7,350 Add To Cart
This research report provides key market trends, market forecasts and competitive scenario of the neurostimulation and pain relief devices  in the US through 2020. 
 
The product categories covered in this report include: 
• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
 
Scope
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
• Highlights and compares key product categories for growth trends and revenue forecast.
• Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
• Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 
• Market share of companies.
• Average selling price ($) for each product type (2007 to 2020).
• Recent Events and Developments.
 
Why should you buy?
• Build business strategy by identifying the high growth and attractive market categories. 
• Develop competitive strategy based on competitive landscape. 
• Design capital investment strategies based on forecasted high potential segments. 
• Identify potential business partners, acquisition targets and business buyers. 
• Plan for a new product launch and inventory in advance. 
• Prepare management and strategic presentations using the market data. 
• To review unbiased and independent assessment of the market data. 
Japan Neurostimulation and Pain Relief Devices Market Outlook and Trends Till 2020   $2,450
  • Language: English | #Pages: 24 | Published: May-2015 | Region: Global
Single User price :$2,450 Add To Cart
Enterprise Price :$4,900 Add To Cart
Global Corporate Price :$7,350 Add To Cart
Single User price :$3,007 Add To Cart
Enterprise Price :$6,014 Add To Cart
Global Corporate Price :$18,021 Add To Cart

China is the capital of diabetes of the world with 100 million diabetics. Further the market is estimated to grow many folds as the large proportion of the population is pre-diabetic and which may join the pool in near future. The China Diabetes Management Devices market comprises continuous glucose monitors (CGM), SMBG (Self-monitoring blood glucose meters), manual insulin delivery products, glucose test strips, lancets, syringes, insulin pens and insulin pumps.

Growth of diabetes market in China is driven by high prevalence of diabetes among the aging population, increased life expectancy, surge in sedentary life style, unhealthy diet, high stress levels and increased disposable income. Also, to a large extent the market in terms of volume is boosted by low priced local products which make the treatment affordable and the adoption of new technology products such as insulin pump and CGM in hospital segment and insulin delivery products as well SMBG in home care segment.

 ‘China Diabetes Management Devices – Market Trends, Forecast and competitive Landscape, 2007 – 2020’, a market intelligence report recently published by ABMRG, covers most of the diabetes management and diagnostic devices. It provides historical and statistically refined forecast data for the segments covered.

 It not only puts forth a detailed overview of historical trends and forecasts (2007-2020), the annualized trends for sales in terms of value and volume, market growth, pricing (Average Selling Price or ASP), competitive landscape and market share, but offers a cross-category comparison, market drivers, market restrains and challenges. In addition, it presents an inclusive account of global industry developments for the past two years, including M&As, partnerships, clinical studies, pipeline, product approvals and launches, recalls and litigations, market dynamics and market drivers and restrains.

The key players in this market are Abbott Laboratories (NYSE: ABT), ARKRAY INC., B. Braun Melsungen AG, Becton, Dickinson and Company (NYSE: BDX), F. Hoffmann-La Roche Ltd (ROG: SIX), Johnson & Johnson (NYSE: JNJ), Lifescan, Inc., Medtronic, Inc. (NYSE: MDT), Novo Nordisk A/S (Copenhagen: NOVOb.CO #Reuters; NYSE: NVO), San Meditech (Huzhou) Co. Ltd, Terumo CORPORATION (TSE: 4543).

Why one should buy this report

The report can be instrumental in making strategic decisions pertaining to:

 

ASEAN and Oceania Respiratory Devices and Diagnostics Market Through 2021   $14,600
  • Language: English | #Pages: 254 | Published: May-2015 | Region: Global
Single User price :$14,600 Add To Cart
Enterprise Price :$17,300 Add To Cart
Global Corporate Price :$22,700 Add To Cart

Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD

 

The only report on ASEAN respiratory devices with a detailed analysis of:

- Hospitals and retail channels

- Respiratory equipment—therapeutic, monitoring and diagnostic

- Markets such as Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam as well as Australia, New Zealand and Bangladesh

http://www.abmrg.com/ASEAN-and-Oceania-Respiratory-Devices-and-Diagnostics-Market-Through-2021.html

The respiratory devices and diagnostics market comprises diagnostic devices such as spirometers and peak flow meters, monitoring devices like capnographs and pulse oximeters and therapeutic devices that include oxygen concentrators, nebulisers, Continuous Positive Airway Pressure (CPAP) devices, etc.  The growth in ASEAN and Oceania respiratory devices and diagnostics market is anticipated to accelerate in coming years due to an increase in prevalence of chronic respiratory diseases like Chronic Obstructive Pulmonary Diseases (COPD), asthma and Obstructive Sleep Apnea (OSA) in both aging as well as young population in this region. ASEAN, Oceania and other APAC cover Australia, Bangladesh, Indonesia, Malaysia, Myanmar, New Zealand, Philippines, Singapore, Thailand and Vietnam.

The prevalence of respiratory diseases, especially asthma, is very high in the Oceania region and it is increasing in ASEAN countries due to growing smoking habit, air pollution, aging population, unhealthy diet and physical inactivity leading to COPD and OSA. Due to the collective size of Indo-China market, ASEAN countries’ potential is underestimated. ASEAN is expected to boost growth in the APAC region. For instance, Indonesia is highly populated with considerable cases of chronic respiratory diseases and low treatment penetration rates. We are expecting penetration to improve with government initiatives like mobile community health services and government-financed health coverage program.

Respiratory devices are divided in to two segments—Homecare devices and Hospital care devices. Though, Hospital is a leading segment, the demand for Homecare devices is increasing for all products in the Oceania region while the demand is surging for low-value products such as nebulisers and peak flow meters along with related disposables in the ASEAN region.

The demand for disposable consumables has increased over reusable ones due to safety concerns, a decline in prices of consumables, an increase in disposable income and improving diagnostics facilities.

A large number of players attracted to the low entry barrier high volume nature of the ASEAN market, has made the market highly fragmented and unorganised. Hospitals prefer economical devices if scrap life of the device is short and replacement is more economical than repair. Economical disposables are preferred in the case of patients who are provided home care due to cost benefits. Hospitals prefer local or Chinese disposables due to higher margins compared with products from multi-national companies (MNCs).

The key players in this market are AirSep Corporation, a division of Chart Industries, CareFusion Corp (NYSE : CFN), Covidien plc, DeVilbiss Healthcare LLC, Fisher & Paykel Healthcare Corp Ltd (NZE : FPH), Invacare Corporation, Omron Healthcare, Inc., a division of Omron Corporation (6645: TSE), Philips Respironics, Inc., a division of Koninklijke Philips N.V. (AMS : PHIA, NYSE : PHG), ResMed Inc (NYSE: RMD).

ASEAN and Oceania Respiratory Devices and Diagnostics Market through 2020 - Detailed Analysis of Hospital and Retail market, a market report recently published by ABMRG, reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), channel-wise revenue distribution for hospitals and retail, market growth, pricing, competitive landscape as well as overall and channel-wise market share.

It offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines, product approvals and launches, recalls and litigations, market dynamics, market drivers and restraints.

Why one should buy this report 

The report can be instrumental in formulating strategic decisions to:

·         Make a business development strategy for the respiratory devices in ASEAN and Oceania region.

·         Frame a distribution strategy in the ASEAN and Oceania region based on a detailed analysis of hospitals and the retail channel market.

·         Launch competitive respiratory devices for individual countries.

·         Make capital investments based on the forecast for high potential markets.

·         Capitalize on opportunities in high-growth geographies and attractive respiratory devices markets.

·         Identify in-licensing and out-licensing opportunities, and spot potential business partners and M&A targets within the respiratory devices market.

·         Help respiratory devices
companies procure raw materials and inventory well in advance.

·         Prepare management and strategic presentations for investors and shareholders.

 

Other strategic market reports by ABMRG: 

-          Russia Oxygen Concentrators Market - Trends and Market Forecast 2019

http://www.abmrg.com/Russia-Oxygen-Concentrators-Market---Trends-and-Market-Forecast-2019.html

-          North America Respiratory Disposable and Anesthesia Disposable Device Market - Growth Trends and Potential 2006-2019

http://www.abmrg.com/North-America-Respiratory-Disposable-Device-Market-Trends-and-Potential-2006-2019.html

About ABMRG

ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on medical technology and pharmaceuticals. It offers comprehensive research and analytical studies targeting companies, therapeutic sectors and countries, highlighting market dynamics, vital trends, business strategies, clinical pipeline and technology advancements. Its cutting edge reports help companies make smarter, effective and faster strategic decisions for business growth. For detailed table of contents of  ASEAN and Oceania Respiratory Devices and Diagnostics Market Through 2021. contact

Contact:

Ankit Jian - sales@abmrg.com ; 19@abmrg.com

+91 – 8238155239; +91 - 261-2216406

 

Single User price :$13,007 Add To Cart
Enterprise Price :$14,006 Add To Cart
Global Corporate Price :$15,005 Add To Cart

 

India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information—City, State and National)

-No one has covered cath labs in India like us: ABMRG

-Primary research covering 700 angioplasty centres in 150 cities

-Comparative analysis among states & regions; hospital chains; govt & pvt hospitals

http://www.abmrg.com/India-Coronary-Stent-and-Angioplasty-Market-Through-2020-Cath-lab-level-Information---City-State-and-National-.html

The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 million in 2012. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES. The key players operating in the segment are Alvimedica, Abbott Vascular, a division of Abbott Laboratories (NYSE : ABT), Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. (NYSE :MDT), Meril Life Sciences, MicroPort Scientific Corporation (HKG: 0853), Sahajanand Medical Technologies and Translumina Therapeutics.

 

The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals.

 

The demand has surged as central and state governments capped reimbursement rates which enhanced affordability resulting in an increase in volume. The decrease in reimbursement rates has given an edge to Indian, Asian and some of the Europe-based mid-sized MNCs which sell stents at almost half the price of those sold by US companies.

In the US, the stents market has slumped significantly due to negative results from clinical studies suggesting that one-third of stent implants are unnecessary. However, in India these studies have not made an impact as most Indian cardiologists do not seem to have taken these clinical outcomes seriously.

India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information—City, State and National)’, is a market report published recently by ABMRG. It reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), market growth, pricing, competitive landscape and market share.

The research report covers 700 cath labs across the country. It analyses angioplasty procedures’ (PCI and PTCA) data for the country with a detailed analysis at national, state, district, city and hospital levels. It provides PCI data of 550 hospitals from more than 150 cities. 

The report offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines (R&D), product approvals and launches, recalls and litigations, market dynamics, market drivers and restraints.

Why one should buy this report - No one has covered cath labs in India like us.

The report can be instrumental in formulating strategic decisions to:

  • Make a regional strategy based on regional landscape and market characteristics.
  • Capitalise on opportunities in high-growth angioplasty regions/markets.
  • Plan capital investments based on the forecast for high angioplasty markets.
  • Prepare strategic presentations for the management, investors and shareholders.

Other strategic market reports: 

-          Global Coronary Stent Market Outlook Through 2019

http://www.abmrg.com/Global-Coronary-Stent-Market-Outlook-Through-2019.html

-          EU-7 Coronary Stents Market Outlook Through 2019

www.abmrg.com/EU-7-Coronary-Stents-Market-Outlook-Through-2019.html

-          European Interventional Cardiology Market through 2020

http://www.abmrg.com/European-Interventional-Cardiology-Market-through-2020.html

 

About ABMRG

ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on life sciences. It offers comprehensive research and analytical studies targeting various therapeutic sectors and its market dynamics, vital trends, business strategies and clinical pipeline. Its cutting edge reports empower companies to make smarter, effective and faster strategic decisions for business growth.

Contact:

Ankit Jian - sales@abmrg.com ; 19@abmrg.com

+91 – 8238155239; +91 - 261-2216406

Source: ABMRG

Single User price :$13,501 Add To Cart
Enterprise Price :$15,007 Add To Cart
Global Corporate Price :$18,506 Add To Cart

The report, 'India Joint Replacement - Market Size, Procedure Volume, Growth Trend at City, State and National Level'  provides a detailed analysis of joint replacement surgeries in 740 hospitals from more than 200 cities. It reviews market drivers, restraints, historical trends and forecasts (for the period from 2007 to 2020), annualised trends for sales in terms of value and volume (in dollar terms and units), market growth, pricing, competitive landscape and market share. It offers a cross-category comparison for THR and TKR (Total Hip Replacement and Total Knee Replacement) as well as shoulder joint replacement for the historical and forecast period.

Why one should buy this report  

  • To get a detailed analysis of the joint replacement market and joint replacement surgeries for over 740 hospitals in more than 200 cities.
  • To make a regional strategy based on regional landscape and regional market characteristics.
  • To capitalise on opportunities in high-growth regions and attractive joint arthroplasty markets.
  • To understand market dynamics at macro and micro level by analysing city and nation level trends.
  • To plan and make capital investments based on the forecast for high potential joint replacement segments.
  • To prepare management and strategic presentations for the investors and shareholders.

The joint replacement market in India grew in double digits between 2007 and 2014. The joint replacement market comprises Total Hip Replacement (THR), Total Knee Replacement (TKR), partial knee replacement, partial hip replacement, shoulder joint replacement and other small joint replacement surgeries. Of these, THR and TKR account for the bulk of revenues.

The key factors fuelling the growth of joint replacement surgeries in India are an increasing number of trained joint replacement surgeons, aging population, sedentary lifestyle, rising health care expenditure, improved healthcare infrastructure and medical tourism. Improved implant designs and a wide choice of implants have also helped surgeons choose the implant that best suits the needs of each patient.  

As per ABMRG's study, in India most people above 60 years suffer from some kind of bone and joint disease and many of them have an immediate need for joint replacement surgery. High prevalence of arthritis primarily in north and south India and increasing prevalence of osteoporosis among post-menopausal women in urban areas who follow a sedentary lifestyle have stimulated the growth of the joint replacement market. Availability of trained orthopaedic surgeons and improved facilities in hospitals have also increased the number of patients opting for joint replacement surgeries. Unlike in western countries, in India the fear of failure of surgery and post-surgery infections among the patients do not affect the joint replacement market as most patients are ignorant about complications and history of product recalls.

India has also witnessed a boom in medical tourism over the years due to longer waiting time for joint replacement in European countries, very limited availability of doctors with expertise in joint replacement procedures in Africa and the Middle East and low procedure costs for joint replacement surgeries in India. In addition to cost benefits, a large number of NRIs prefer to get the procedure done in India as they have high level of confidence in Indian surgeons' expertise.

The Indian joint replacement market is packed with local and multinational companies. Despite higher prices and a history of product recalls, MNCs dominate the Indian market due to surgeons' preference and patients' desire for imported implants. In mid to long term, we expect local companies to steal the market share from MNCs. However, MNCs are anticipated to lead the rally at least for another decade.

The key players in the India joint replacement market are Aesculap, a division of B. Braun Melsungen AG; Biomet, Inc.; Orthovasive, a division of Biorad Medisys Pvt. Ltd; DePuy Medical Pty. Ltd, a subsidiary of Johnson & Johnson (NYSE: JNJ); Exatech, Inc.; Maxx Medical Pvt. Ltd; Smith & Nephew plc (NYSE: SNN; LSE: SN); Stryker Corporation (NYSE: SYK) and Zimmer Holdings Inc (NYSE: ZMH, Nasdaq: ZMH).

The report on joint replacements in India also outlines joint replacement product pipeline and highlights findings of global clinical studies. In addition, it lists developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines, product approvals and launches, recalls and litigations, market dynamics, market drivers and restrains.

Other strategic market reports:  

  • APAC Joint Replacement And Joint Reconstruction Market Through 2020

http://www.abmrg.com/APAC-Joint-Replacement-And-Joint-Reconstruction-Market-Through-2020.html

  • Australia Joint Reconstruction Market Outlook, 2007-2020

http://www.abmrg.com/Australia-Joint-Reconstruction-Market-Outlook-2007-2020.html

  • UK Joint Reconstruction Market Forecast To 2020

http://www.abmrg.com/UK-Joint-Reconstruction-Market-Forecast-To-2020.html

  • India Joint Reconstruction Market Trends Forecast To 2020

http://www.abmrg.com/India-Joint-Reconstruction-Market-Trends-Forecast-To-2020.html

  • European Hip Replacement Market Through 2020- Opportunities, Trends and Pipeline Analysis

http://www.abmrg.com/European-Hip-Replacement-Market-Through-2020---Opportunities-Trends-And-Pipeline-Analysis.html

About ABMRG 

ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on medical technology and pharmaceuticals. It offers comprehensive research and analytical studies targeting company, country and therapeutic sector, highlighting market dynamics, vital trends, business strategies, clinical pipeline and technology advancements. Its cutting edge reports empower companies to make smarter, effective and faster strategic decisions for business growth.

Contact: 

Ankit Jian 
+91-8238155239
+91-261-2216406
sales@abmrg.com
19@abmrg.com

 

 

 1    2   | 3   | 4   | 5   | >   | >>   

Page 1 of 230   showing records 1 to 10 of 2298 in this selection